Market Cap
$263.1M
ANIK
Anika Therapeutics, Inc.
$19.10 ▼ -1.34%
Prev close $19.36Market cap$263.1M
ConsensusStrong Buy
12-mo target$23.00 (+20.4%)
▲ Bullish
Analyst conviction 9/10
Insider Buying Cluster (2 insiders)High Impact Filing (8/10)17 New Institutional Positions7 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on ANIK right now — valuation, ownership and activity at a glance.
Cap Size
Micro Cap
Analyst Consensus
Strong Buy (88%)
Inst. Holders
50 funds
Inst. Value
$122.4M
Inst. Activity
17 buys / 7 sells
Insider Activity
$264.3K buy / $0.00 sell
Insider Net $
$264.3K
SEC Reports
11
Price chart 30d -9.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 4, 2026 Insider
Fischetti Gary P bought 1,000 shares
Director @ $20.32 ($20.3K)
Aug 3, 2026 Insider
Jul 29, 2026 SEC Fischetti Gary P bought 1,000 shares
Director @ $20.75 ($20.7K)
Anika Therapeutics reported a transformative Q2 2026 beat, with GAAP EPS of $0.24 (vs $0.03 consensus) and revenue of $3
8-K — Impact 8/10
Jul 29, 2026 earnings
Jul 14, 2026 SEC Anika Reports Second Quarter 2026 Financial Results
Commercial Channel Revenue Increased 17% to a Record $13.9 Million
Anika Therapeutics entered into a Fifth Amendment to its existing credit agreement with Bank of America on July 10, 2026
8-K — Impact 3/10
Jun 30, 2026 Inst.
MORGAN STANLEY — TRIM
614,320 shares ($9.0M)
Jun 30, 2026 Inst.
Jun 24, 2026 SEC Nuveen, LLC — ADD
156,538 shares ($2.3M)
Anika Therapeutics held its 2026 Annual Meeting on June 18, 2026. Stockholders approved an amendment to the 2017 Omnibus
8-K — Impact 4/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
88% rate it Buy or better · 8 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Jul 30, 2026 | B. Riley Securities | MAINTAIN | Buy | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Aug 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Jul 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Jun 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Apr 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Mar 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 3 | 4 | 1 | 0 | 0 | 88% |
Price targets
Where 2 covering analysts think ANIK trades over the next 12 months.
$23.00 +20.4% upside Strong Buy
Current$19.10 Low$23.00 Median$23.00 High$23.00 2 analysts
$23.00$23.00
Analyst rating Strong Buy· 1.5/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
11 SEC filing reports analyzed · 1 bullish, 1 bearish, 3 mixed, 6 neutral · avg impact 4.4/10.
BULLISH8-K8/10
Anika Therapeutics reported a transformative Q2 2026 beat, with GAAP EPS of $0.24 (vs $0.03 consensu
Jul 29, 2026
NEUTRAL8-K3/10
Anika Therapeutics entered into a Fifth Amendment to its existing credit agreement with Bank of Amer
Jul 14, 2026
NEUTRAL8-K4/10
Anika Therapeutics held its 2026 Annual Meeting on June 18, 2026. Stockholders approved an amendment
Jun 24, 2026
BEARISHINST-CLUSTER4/10
An institutional cluster for ANIK shows 4 small asset managers adding a combined $33K, while Citadel
Jun 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Jul 29, 2026
earnings
Anika Reports Second Quarter 2026 Financial Results
Commercial Channel Revenue Increased 17% to a Record $13.9 Million
Jul 29, 2026
earnings_calendar
ANIK Q2 2026 Earnings Scheduled — 2026-07-29
Jul 15, 2026
earnings
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention o
Jun 5, 2026
other
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=c01BYhTYq6orCPlUpNrw-c1u-UPDWTkeerfy_E51pNQ
Apr 29, 2026
earnings
Anika Reports First Quarter 2026 Financial Results
Grew total company revenue 13%, driven by Commercial Channel strength and favorable OEM Channel order timing
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.42 | $0.42–$0.42 | 950.0% | +147.1% | 0↑ 1↓ | $0.0B | 1 |
| Next Q | $0.19 | $0.19–$0.19 | -38.7% | +0.0% | 0↑ 1↓ | $0.0B | 1 |
| Current FY | $1.05 | $1.05–$1.05 | 854.6% | +0.0% | 0↑ 1↓ | $0.1B | 1 |
| Next FY | $0.95 | $0.95–$0.95 | -9.5% | +0.0% | 1↑ 0↓ | $0.1B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.420 | — |
| 7d ago | $0.170 | +0.250 |
| 30d ago | $0.170 | +0.250 |
| 60d ago | $0.170 | +0.250 |
| 90d ago | $0.030 | +0.390 |
Institutional ownership
Which big funds own ANIK (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $122.4M total value (8,366,577 shares) as of 2026-Q2. Top holders: BlackRock,, MORGAN, VANGUARD. Net buying activity: 17 institutions added/increased vs 7 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 1,449,671 | $21.2M | 17.3% | — |
| MORGAN STANLEY | 614,320 | $9.0M | 7.3% | TRIM -29.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | 572,113 | $8.4M | 6.8% | — |
| AQR CAPITAL MANAGEMENT LLC | 559,846 | $8.2M | 6.7% | DOUBLED +293.0% |
| RENAISSANCE TECHNOLOGIES LLC | 481,417 | $7.0M | 5.8% | — |
| DIMENSIONAL FUND ADVISORS LP | 451,095 | $6.6M | 5.4% | — |
| DEUTSCHE BANK AG\ | 353,552 | $5.2M | 4.2% | DOUBLED +334.5% |
| GEODE CAPITAL MANAGEMENT, LLC | 331,577 | $4.9M | 4.0% | — |
| STATE STREET CORP | 311,896 | $4.6M | 3.7% | — |
| TWO SIGMA INVESTMENTS, LP | 252,964 | $3.7M | 3.0% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 872,066 | 614,320 | -29.6% | $9.0M |
| Nuveen, LLC | ADD | 120,717 | 156,538 | +29.7% | $2.3M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | DOUBLED | 31,354 | 106,644 | +240.1% | $1.6M |
| JANE STREET GROUP, LLC | ADD | 54,424 | 85,257 | +56.7% | $1.2M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | 47,221 | 63,953 | +35.4% | $935.6K |
| Assenagon Asset Management S.A. | ADD | 46,586 | 63,016 | +35.3% | $921.9K |
| JPMORGAN CHASE & CO | ADD | 34,300 | 54,215 | +58.1% | $813.8K |
| STATE OF WISCONSIN INVESTMENT BOARD | TRIM | 45,729 | 33,900 | -25.9% | $496.0K |
| IEQ CAPITAL, LLC | ADD | 19,678 | 33,466 | +70.1% | $489.6K |
| Trexquant Investment LP | TRIM | 64,053 | 30,888 | -51.8% | $451.9K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
9 insiders, 38 transactions. Net $264.3K — $264.3K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Fischetti Gary P | Director | BUY | 1,000 | $20.32 | $20.3K |
| Aug 3, 2026 | Fischetti Gary P | Director | BUY | 1,000 | $20.75 | $20.7K |
| Jun 18, 2026 | Capper Joseph H | Director | AWARD | 10,402 | — | — |
| Jun 18, 2026 | HENNEMAN JOHN B III | Director | AWARD | 10,402 | — | — |
| Jun 18, 2026 | CONLEY SHERYL L | Director | AWARD | 10,402 | — | — |
| Jun 18, 2026 | Richard Stephen | Director | AWARD | 10,402 | — | — |
| Jun 18, 2026 | Fischetti Gary P | Director | AWARD | 10,402 | — | — |
| May 1, 2026 | HENNEMAN JOHN B III | Director | BUY | 5,000 | $14.66 | $73.3K |
| Apr 30, 2026 | Griffin Stephen D. | President and CEO | BUY | 12,200 | $12.29 | $149.9K |
| Mar 19, 2026 | McLeod Ian | SVP, CAO & Treasurer | AWARD | 13,097 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for ANIK.
Shares short
381,376
Settlement Sep 15, 2026
Change vs prior
+10.4%
Semi-monthly cycle
Days to cover
5.4
At avg daily volume
Of shares outstanding
≈2.9%
Estimate — not % of float
All ANIK filing & press-release reports (11)
- 8-K reportJul 29, 2026
- 8-K reportJul 14, 2026
- 8-K reportJun 24, 2026
- INST-CLUSTER reportJun 11, 2026
- DEFA14A reportJun 8, 2026
- DEFA14A reportJun 1, 2026
- CLUSTER reportMay 4, 2026
- 8-K reportApr 29, 2026
- DEFA14A reportApr 28, 2026
- PRESS-RELEASE reportApr 15, 2026
- 8-K reportFeb 26, 2026